Synthesis of Fused 4,5-Disubstituted Indole Ring
Systems by Intramolecular Friedel-Crafts
Acylation of 4-Substituted Indoles
Eric Fillion* and Aaron M. Dumas
Department of Chemistry, UniVersity of Waterloo, Waterloo,
Ontario N2L 3G1, Canada
ReceiVed December 4, 2007
FIGURE 1. Examples of 3,4- and 4,5-substituted indole natural
products.
SCHEME 1. Intramolecular FC Acylation of 4-Substituted
Indoles To Yield 3,4-Bridged and 4,5-Fused Products
4-Substituted indoles containing a variety of electrophiles
and N-substituents undergo Friedel-Crafts acylation to give
exclusively the products of cyclization at the 5-position of
indole. These indanones and tetralones have been scarcely
prepared and are subunits in natural products and analogues
of potential biological significance.
Indole-containing natural products and bioactive molecules
represent a substantial portion of alkaloids, and as such have
been the subject of innumerable synthetic forays. We were
particularly interested in 3,4-bridged and 4,5-fused indole-
containing molecules (indole numbering), which include the
ergot alkaloids1 (such as festuclavine) and hapalindoles/am-
biguines2 and lolitrems and lolicines,3 respectively (Figure 1).
Retrosynthetically, intramolecular Friedel-Crafts (FC) acy-
lation of 4-substituted indoles appears to be a logical discon-
nection to access these ring systems. FC acylation has been
among the most powerful and widely used means of function-
alizing arenes, which makes the lack of examples of this reaction
as it pertains to 4-substituted indoles surprising.4,5 FC acylation
with Vilsmeier-Haack reagents derived from N,N-dimethyla-
mides, reported by Ishikawa,6 and carboxylic acids, reported
by Spadoni,7 cyclize from the 4- to the 3-position of indole
exclusively (Scheme 1a).8 In both of these cases, the indole
nitrogen was unprotected, although in the latter case the
5-position was blocked. Boger disclosed the cyclization of an
acid chloride to the 5-position in a comparatively deactivated
2-carbomethoxyindole (Scheme 1b). Indoles containing this 4,5-
indanone motif are of medicinal relevance as such a substructure,
appended to the CPI unit of CC-1065, greatly increases the
cytotoxicity of the analogues.9
Based on this precedent, the factors affecting the regioselec-
tivity of the acylation are unclear. Considering the potentially
wide range of products available by these routes, we undertook
a study of the regioselectivity of FC acylations of 4-substituted
indoles. These studies focused on the effect of changing the
electrophile, the N-protecting group, and the tether length
(Scheme 2).
The intramolecular FC acylation of Meldrum’s acid deriva-
tives was chosen as the initial probe reaction, as the molecules
are easily prepared and functionalized, but are highly reactive
FC acylating agents.10 These are conveniently synthesized by
Knoevenagel condensation of an aldehyde with Meldrum’s acid
(3).11 In this case, the π-nucleophilicity of indole-4-carboxal-
(1) Rˇeha´cˇek, Z.; Sajdl, P. Ergot Alkaloids: Chemistry, Biological Effects,
Biotechnology; Elsevier: New York, 1990.
(2) Isolation of ambiguine H: Smitka, T. A.; Bonjouklian, R.; Doolin,
L.; Jones, N. D.; Deeter, J. B. J. Org. Chem. 1992, 57, 857-861.
(3) Isolation of lolicine A: Munday-Finch, S. C.; Wilkins, A. L.; Miles,
C. O. J. Agric. Food Chem. 1998, 46, 590-598.
(4) Examples of FC alkylation of 4-substituted indoles: (a) Natsume,
M.; Muratake, H. Tetrahedron Lett. 1989, 30, 1815-1818. (b) Matsumoto,
M.; Watanabe, N.; Kobayashi, H. Heterocycles 1987, 26, 1479-1482.
(5) A related anionic cyclization of a 4-substituted indole to the 3-position
was reported in a total synthesis of lysergic acid: Hendrickson, J. B.; Wang,
J. Org. Lett. 2004, 6, 3-5.
(7) Spadoni, G.; Balsamini, C.; Diamantini, G.; Di, Giacomo, B.; Tarzia,
G.; Mor, M.; Plazzi, P. V.; Rivara, S.; Lucini, V.; Nonno, R.; Pannacci,
M.; Fraschini, F.; Stankov, B. M. J. Med. Chem. 1997, 40, 1990-2002.
(8) For an example of cyclization from the 3- to the 4-position of indole,
see: Komoda, T.; Nakatsuka, S. Heterocycl. Commun. 2003, 9, 119-122.
(9) Boger, D. L. Int. Patent WO2004101767, 2004.
(6) Kurokawa, M.; Watanabe, T.; Ishikawa, T. HelV. Chim. Acta 2007,
90, 574-587.
10.1021/jo702591p CCC: $40.75 © 2008 American Chemical Society
Published on Web 03/06/2008
2920
J. Org. Chem. 2008, 73, 2920-2923